Press Release Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights 5 November 2025
Press Release Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 5 November 2025
Press Release Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032 5 November 2025
Press Release Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program 5 November 2025
Press Release Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program 5 November 2025
